Cristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.
Show Notes
(
00:31)
Could you provide our listeners with a little bit about yourself and your background?
(
01:48)
Could you give an overview of the new neuro-oncology expanded gene panel by next generation sequencing?
Can you describe a little bit more about some examples of genes that were in the 2021 WHO classification that are now included in the NONCP panel?
(
06:50)
Does this panel have high clinical utility in both in adult and pediatric cases?
(
08:05)
Is picking up on copy numbers useful in both adult and pediatric cases?
(
09:12)
Could you discuss a little bit more about how these results would be used in patient care?
(
10:27)
Do you have anything else you would like to add about the enhanced neuro-oncology NGS panel?
What is Answers from the Lab?
A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.